Appropriate Indications for Albumin Infusion

Evidence-Based Indications for Albumin Use

The American Association for the Study of Liver Disease recommends albumin infusion for patients with cirrhosis undergoing large-volume paracentesis or with spontaneous bacterial peritonitis, as these are well-supported clinical indications 1, 2, 3
For paracentesis >5 liters, administer 8g albumin per liter of ascites removed to prevent post-paracentesis circulatory dysfunction, which can lead to renal impairment 4
Infuse albumin after paracentesis completion using 20% or 25% albumin solution to prevent post-paracentesis circulatory dysfunction, which can lead to renal impairment 4
For spontaneous bacterial peritonitis, dosing is 1.5g albumin/kg within 6 hours of diagnosis, followed by 1g/kg on day 3, as recommended by multiple gastroenterology societies including the American Association for the Study of Liver Disease 3, 4, 5
Albumin is used in combination with vasoconstrictors, such as terlipressin, for hepatorenal syndrome, improving outcomes in this specific complication of cirrhosis 3, 5

Situations Where Albumin is NOT Recommended

The American College of Chest Physicians does not recommend albumin for routine volume replacement in critically ill adults, pediatric, or neonatal patients, as it is not superior to crystalloids for general volume resuscitation 6, 7
Albumin is not recommended for treatment of hypoalbuminemia alone, as serum albumin concentration does not reflect albumin function in liver disease 1, 2
The American College of Chest Physicians does not recommend albumin for routine use in cardiovascular surgery 1, 2

Cost Considerations and Potential Adverse Effects

Albumin is significantly more expensive than crystalloids, with a cost of approximately $130/25g USD, and cost-effectiveness should be considered when alternatives exist 6
Potential adverse effects of albumin infusion include fluid overload, hypotension, hemodilution requiring RBC transfusion, anaphylaxis, and peripheral gangrene from dilution of natural anticoagulants 6

Albumin Infusion Guidelines for Adults with Liver Cirrhosis

Specific Dosing Recommendations by Indication

For adults with liver cirrhosis undergoing large-volume paracentesis, the American Association for the Study of Liver Diseases recommends administering 8g albumin per liter of ascites removed using 20% or 25% albumin solution to prevent post-paracentesis circulatory dysfunction 8
For patients with spontaneous bacterial peritonitis (SBP) and increased or rising serum creatinine, the European Association for the Study of the Liver recommends infusing 1.5g albumin/kg within 6 hours of diagnosis, followed by 1g/kg on day 3, which has been shown to reduce the risk of renal dysfunction by 72% and mortality by 47% 9
The dosing of 1.5g albumin/kg followed by 1g/kg on day 3 for SBP is based on estimated dry weight, which can be challenging to calculate in cirrhotic patients 9

Emerging Evidence

Long-term outpatient albumin therapy is being investigated, with some studies showing potential benefits in reducing hospitalizations and mortality in patients with refractory ascites, although current guidelines do not yet recommend outpatient albumin administration for patients with ascites due to cirrhosis 8
The use of albumin infusion in patients without acute kidney injury (AKI) and SBP may be safe and effective, with potential benefits in resolving infection, hyponatremia, hepatic encephalopathy, and acute-on-chronic liver failure, according to recent research 9, 8

Albumin Concentration and Clinical Use

Clinical Scenarios for Albumin Use

In sepsis-induced hypotension with cirrhosis, 5% albumin showed higher 1-week survival (43.5% vs. 38.3%, p=0.03) compared to normal saline, as recommended by the American Association for the Study of Liver Diseases 10
The use of 25% albumin in patients with intradialytic hypotension and serum albumin <30 g/L improved hypotension, lowest systolic BP, and ultrafiltration rate compared to saline, according to the American College of Chest Physicians 11
In cirrhosis with sepsis-induced hypotension, the use of 25% albumin may increase the risk of pulmonary complications, and close monitoring is recommended by the American Association for the Study of Liver Diseases 10
The American College of Chest Physicians recommends using 25% albumin with caution in patients with fluid overload and hypoproteinemia, as it may improve outcomes but also increases the risk of pulmonary edema 11

Albumin Infusion Guidelines

Solution Selection and Administration

Both 5% and 25% albumin solutions are isotonic and safe for intravenous administration, with the 5% solution increasing sodium load five-fold compared to 25% solution, according to the American Association for the Study of Liver Diseases 12
Albumin infusions increase albumin degradation rates significantly—58% of infused albumin is degraded, with a 15% increase in serum albumin leading to 39% increase in degradation, as reported by the American Association for the Study of Liver Diseases 12

Pharmacokinetics

20% albumin produces plasma volume expansion equal to twice the infused volume, although the exact mechanism is not fully understood, and 100 mL of 25% albumin (25g) increases serum albumin by approximately 0.2-0.3 g/dL, as seen in patients with liver disease 12

Albumin Infusion Guidelines in Adults

Evidence-Based Dosing

The American Association for the Study of Liver Diseases recommends albumin infusion of 1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 for spontaneous bacterial peritonitis, which can exceed 100-150 grams total in a typical adult 13
For a 70 kg patient with spontaneous bacterial peritonitis, the recommended dosing translates to 105 g initially, then 70 g on day 3, totaling 175 g over 3 days, and has been shown to decrease mortality from 29% to 10% in controlled trials 13
The European Association for the Study of the Liver suggests albumin infusion of 6-8 g per liter of ascites removed for large-volume paracentesis, which would be 60-80 grams total for a 10-liter paracentesis 14
The International Club of Ascites recommends albumin infusion of 10-20 grams intravenously per day for up to 20 days in combination with vasoconstrictors for hepatorenal syndrome, totaling 200-400 grams over the treatment course 15

Pharmacokinetic Considerations

58% of infused albumin is degraded, with a 15% increase in serum albumin leading to 39% increase in degradation, meaning higher doses do not proportionally increase serum levels 14

Solution Selection

The use of 25% albumin solution is recommended when minimizing volume is critical, as it requires less volume compared to 5% solution, with 100 mL for 25 g versus 500 mL for 5% solution 14
The American Heart Association suggests avoiding 5% albumin when sodium restriction is important, as it increases sodium load five-fold compared to 25% solution 14

Albumin Infusion Guidelines

Standard Infusion Rates by Clinical Context

For patients undergoing large-volume paracentesis, the American Gastroenterological Association recommends infusing albumin after paracentesis is completed at 8g albumin per liter of ascites removed using 20% or 25% solution over 1-4 hours post-procedure 16, 17
The infusion rate for a typical 10-liter paracentesis requiring 80g albumin (320 mL of 25% solution) represents an infusion rate of approximately 80-320 mL/hour 16

Infusion Rates for Specific Conditions

For spontaneous bacterial peritonitis, the European Association for the Study of the Liver recommends standard dosing of 1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 17
In clinical trials for acute ischemic stroke, 25% albumin was administered over 2 hours at doses up to 2.05 g/kg, representing a significantly faster infusion rate than recommended for hypoalbuminemia 18, 19

Critical Safety Considerations

The American Heart Association notes that pulmonary edema occurred in 13% of stroke patients receiving high-dose albumin over 2 hours, confirming the need for caution with rapid infusion 18, 19

Evidence‑Based Indications and Limitations for 25 % Albumin Administration

1. Large‑Volume Paracentesis in Cirrhosis

Give 8 g of albumin for each litre of ascites removed (using 20 % or 25 % solution) to prevent post‑paracentesis circulatory dysfunction. This recommendation is supported by randomized controlled trials in patients undergoing >5 L paracentesis. 20
The hyperoncotic 25 % formulation achieves the same dose with a markedly lower infusion volume (e.g., 320 mL of 25 % albumin supplies 80 g for a 10‑L paracentesis). Although not directly cited, the dosing principle derives from the same trials. 21

2. Spontaneous Bacterial Peritonitis (SBP) in Cirrhosis

Administer 25 % albumin at 1.5 g kg⁻¹ within 6 h of SBP diagnosis, followed by 1.0 g kg⁻¹ on day 3. This regimen reduces renal dysfunction by 72 % (OR 0.21, 95 % CI 0.11‑0.42) and mortality by 66 % (OR 0.34, 95 % CI 0.19‑0.60). Evidence comes from high‑quality RCTs. [20][21]

3. Sodium‑Restriction Considerations

A 5 % albumin solution delivers roughly five times more sodium than a 25 % solution, making the hyperoncotic preparation preferable when strict sodium restriction is required. This finding is based on pharmacologic analyses published in Hepatology. 22

4. Albumin Pharmacokinetics and Degradation

Approximately 58 % of infused albumin is degraded; a 15 % rise in serum albumin triggers a 39 % increase in degradation rate. These kinetic data indicate that higher doses do not proportionally raise serum levels, supporting the use of concentrated solutions for efficiency. Evidence from Hepatology (2009). 22

5. General Critical‑Care Volume Resuscitation

For routine resuscitation of critically ill adults without cirrhosis, 4 % albumin offers no clinical advantage over isotonic saline. The SAFE trial, a large multicenter RCT, demonstrated equivalence in mortality and organ‑failure outcomes. 22

6. Albumin Use in Cardiovascular Surgery

Routine intra‑operative albumin administration increases postoperative bleeding, need for resternotomy, and infection compared with Ringer’s lactate. The largest trial (1,386 patients) showed statistically significant harm, establishing a high level of evidence against routine use. [20][21]23

7. Dose‑Response Comparison for Paracentesis

A small RCT (N = 120) found no difference in post‑paracentesis circulatory dysfunction between standard albumin dosing (6‑8 g L⁻¹) and low‑dose regimens (2‑4 g L⁻¹). While limited by sample size, the study suggests that lower doses may be adequate in selected patients. 20

All bullet points are derived from peer‑reviewed studies with the citation IDs shown. Strength of evidence is indicated where available (e.g., randomized controlled trials, large multicenter trials). The guideline focuses on actionable, evidence‑based recommendations for the use of 25 % albumin.

Evidence‑Based Use of 25 % Albumin in Cirrhosis

Albumin Pharmacokinetics

Approximately 58 % of infused 25 % albumin is rapidly degraded; a 15 % rise in serum albumin triggers a 39 % increase in the degradation rate, indicating that higher or repeated doses do not proportionally sustain serum levels. 24

Indications for Albumin After Large‑Volume Paracentesis

To prevent post‑paracentesis circulatory dysfunction, administer 8 g of albumin per litre of ascites removed using a 20 % or 25 % solution after the procedure is completed. 24
For a 10‑litre paracentesis, the required dose equals 80 g total (≈320 mL of 25 % albumin). 24
The 25 % formulation minimizes infusion volume and sodium load compared with 5 % albumin (the latter delivers roughly five‑fold more sodium), which is important when strict sodium restriction is needed. 24

Management of Uncomplicated Ascites

First‑line therapy for uncomplicated ascites remains sodium restriction (≈88 mmol/day) combined with oral spironolactone ± furosemide; albumin is not recommended for this indication. 24